Cargando…

Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?

Universal access to antiretroviral treatment (ART) in Chad was officially declared in December 2006. This presidential initiative was and is still funded 100% by the country’s budget and external donors’ financial support. Many factors have triggered the spread of AIDS. Some of these factors include...

Descripción completa

Detalles Bibliográficos
Autores principales: Azétsop, Jacquineau, Diop, Blondin A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750377/
https://www.ncbi.nlm.nih.gov/pubmed/23902732
http://dx.doi.org/10.1186/1747-5341-8-8
_version_ 1782477112066703360
author Azétsop, Jacquineau
Diop, Blondin A
author_facet Azétsop, Jacquineau
Diop, Blondin A
author_sort Azétsop, Jacquineau
collection PubMed
description Universal access to antiretroviral treatment (ART) in Chad was officially declared in December 2006. This presidential initiative was and is still funded 100% by the country’s budget and external donors’ financial support. Many factors have triggered the spread of AIDS. Some of these factors include the existence of norms and beliefs that create or increase exposure, the low-level education that precludes access to health information, social unrest, and population migration to areas of high economic opportunities and gender-based discrimination. Social forces that influence the distribution of dimensions of well-being and shape risks for infection also determine the persistence of access barriers to ART. The universal access policy is quite revolutionary but should be informed by the systemic barriers to access so as to promote equity. It is not enough to distribute ARVs and provide health services when health systems are poorly organized and managed. Comprehensive access to ART raises many organizational, ethical and policy problems that need to be solved to achieve equity in access. This paper argues that the persistence of access barriers is due to weak health systems and a poor public health leadership. AIDS has challenged health systems in a manner that is essentially different from other health problems.
format Online
Article
Text
id pubmed-3750377
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37503772013-08-24 Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy? Azétsop, Jacquineau Diop, Blondin A Philos Ethics Humanit Med Research Universal access to antiretroviral treatment (ART) in Chad was officially declared in December 2006. This presidential initiative was and is still funded 100% by the country’s budget and external donors’ financial support. Many factors have triggered the spread of AIDS. Some of these factors include the existence of norms and beliefs that create or increase exposure, the low-level education that precludes access to health information, social unrest, and population migration to areas of high economic opportunities and gender-based discrimination. Social forces that influence the distribution of dimensions of well-being and shape risks for infection also determine the persistence of access barriers to ART. The universal access policy is quite revolutionary but should be informed by the systemic barriers to access so as to promote equity. It is not enough to distribute ARVs and provide health services when health systems are poorly organized and managed. Comprehensive access to ART raises many organizational, ethical and policy problems that need to be solved to achieve equity in access. This paper argues that the persistence of access barriers is due to weak health systems and a poor public health leadership. AIDS has challenged health systems in a manner that is essentially different from other health problems. BioMed Central 2013-08-01 /pmc/articles/PMC3750377/ /pubmed/23902732 http://dx.doi.org/10.1186/1747-5341-8-8 Text en Copyright © 2013 Azetsop and Diop; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Azétsop, Jacquineau
Diop, Blondin A
Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?
title Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?
title_full Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?
title_fullStr Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?
title_full_unstemmed Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?
title_short Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?
title_sort access to antiretroviral treatment, issues of well-being and public health governance in chad: what justifies the limited success of the universal access policy?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750377/
https://www.ncbi.nlm.nih.gov/pubmed/23902732
http://dx.doi.org/10.1186/1747-5341-8-8
work_keys_str_mv AT azetsopjacquineau accesstoantiretroviraltreatmentissuesofwellbeingandpublichealthgovernanceinchadwhatjustifiesthelimitedsuccessoftheuniversalaccesspolicy
AT diopblondina accesstoantiretroviraltreatmentissuesofwellbeingandpublichealthgovernanceinchadwhatjustifiesthelimitedsuccessoftheuniversalaccesspolicy